Archive for space act agreement

NASA, Epiomed Therapeutics partner on development of scopolamine nasal spray

HOUSTON — NASA’s Johnson Space Center and Epiomed Therapeutics have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness. 

Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition. Scopolamine is effective and can be administered as a tablet or injected. With a precise dosage, the NASA spray formulation has been shown to work faster and more reliably than the oral form. 

Scopolamine is currently approved as a prescription-only transdermal patch called Transder Scop, manufactured by Novartis, and is indicated to help prevent nausea and vomiting associated with motion sickness. 

“NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness which can be used by NASA, the Department of Defense and world travelers on land, in the air and on the seas,” stated Lakshmi Putcha, developer of the treatment strategy at Johnson. 

A gel formulation of INSCOP was developed and tested under a Space Act Agreement between Johnson and the Naval Aerospace Medical Research Laboratory in Pensacola, Fla. Results from that trial were published in the journal Aviation, Space and Environmental Medicine in April 2010 that suggest INSCOP is a fast-acting and reliable way to prevent and treat motion sickness. 

The U.S. Navy is working on an agreement with Epiomed to test the nasal spray. NASA and Epiomed will collaborate on clinical trials related to the Federal Drug Administration requirements. NASA is transferring sponsorship of future clinical trials and FDA approvals to Epiomed, which will supply the product for use by NASA and others. 

Article source: http://www.drugstorenews.com/article/nasa-epiomed-therapeutics-partner-development-scopolamine-nasal-spray?utm_source=GoogleNews&utm_medium=Syndication&utm_campaign=ManualSitemap

Tags: , , , , <BR/>

NASA Signs Agreement To Develop Nasal Spray For Motion Sickness

/PRNewswire-USNewswire/ – NASA’s Johnson Space Center in Houston and Epiomed Therapeutics Inc. of Irvine, Calif., have signed an agreement to develop and commercialize a NASA-crafted, fast-acting nasal spray to fight motion sickness.

(Logo: http://photos.prnewswire.com/prnh/20081007/38461LOGO)

Under the Space Act Agreement, Epiomed will formulate the drug, called intranasal scopolamine, or INSCOP. Astronauts often experience motion sickness in space. As a result, NASA has conducted extensive research into the causes and treatments for the condition. Scopolamine is effective and can be administered as a tablet or injected. With a precise dosage, the NASA spray formulation has been shown to work faster and more reliably than the oral form.

“NASA and Epiomed will work closely together on further development of INSCOP to optimize therapeutic efficiency for both acute and chronic treatment of motion sickness which can be used by NASA, the Department of Defense and world travelers on land, in the air and on the seas,” said Lakshmi Putcha, developer of the innovative treatment strategy at Johnson.

A gel formulation of INSCOP was developed and tested under a Space Act Agreement between Johnson and the Naval Aerospace Medical Research Laboratory in Pensacola, Fla. Results from that trial were published in the journal Aviation, Space and Environmental Medicine in April 2010 that suggest INSCOP is a fast-acting and reliable way to prevent and treat motion sickness.

The U.S. Navy is working on an agreement with Epiomed to test the nasal spray. NASA and Epiomed will collaborate on clinical trials related to the Federal Drug Administration requirements. NASA is transferring sponsorship of future clinical trials and FDA approvals to Epiomed, which will supply the product for use by NASA and others.

For more about Johnson’s Human Health and Performance Directorate, which developed INSCOP, visit: http://go.nasa.gov/RiKclM

For more on NASA and agency programs, visit: http://www.nasa.gov

SOURCE NASA

Order Reprint

Article source: http://www.sacbee.com/2012/10/12/4906057/nasa-signs-agreement-to-develop.html

Tags: , , , , <BR/>

Epiomed and NASA Sign Space Act Agreement

— IRVINE, Calif. , Oct. 12, 2012 /PRNewswire/ — Epiomed Therapeutics, Inc. (“Epiomed”) announced today that it has entered into a Reimbursable Space Act Agreement (SAA) with the National Aeronautics and Space Administration (NASA) Lyndon B. Johnson Space Center in Houston, Texas for the development, distribution, manufacture and market release of INSCOP, an intra-nasal scopolamine product. A gel formulation of INSCOP has previously been developed and tested under a SAA between NASA-Johnson Space Center and the Naval Aerospace Medical Research Laboratory, Pensacola, FL (NAMRL).  Results from the NAMRL / NASA trial have been published in the journal Aviation, Space, and Environmental Medicine, and suggest that INSCOP is a fast-acting, reliable, operationally suitable, countermeasure for prophylaxis and treatment of motion sickness with a great potential for rescue treatment. In 2010, NAMRL disestablished and became part of the Naval Medical Research Unit – Dayton, OH (NAMRU-D). NAMRU-D is currently working a Cooperative Research and Development Agreement (CRADA) with Epiomed to test an aqueous formulation of INSCOP (INSCOP Spray). The aim of INSCOP Spray development is to offer a fast acting formulation with no notable side-effects experienced with currently marketed formulations of the drug. Epiomed will take responsibility for further development and commercialization of INSCOP, assisted by NASA-HHP (Human Health Performance Directorate) technology, and assume sponsorship of the IND (Investigational New Drug) from NASA under the SAA. David R. Helton, President and CEO of Epiomed, said “NASA and NAMRL did ground breaking work with INSCOP gel. Now Epiomed is dedicated to complete the required clinical evaluations in collaboration with NASA and NAMRU-D to facilitate market release of INSCOP Spray.” 

About Epiomed Therapeutics

Epiomed Therapeutics, Inc. is a privately-held pharmaceutical company engaged in the discovery, and development of novel central nervous system (CNS) drugs, with a primary focus on anti-emetics (anti-vomiting and anti-nausea), anxiolytics and performance sustainment.

About Human Health Performance Directorate (HHP) – Houston

HHP is dedicated to optimize human health and productivity for space exploration by conducting research and developing path changing technologies to assure mission success, optimize human health and productivity in space and on Earth (http://www.nasa.gov/offices/NHHPC/index.html).

For further information, call 1-949-398-7359, or visit www.epiomed.com.

Safe Harbor: This press release contains certain forward-looking information about Epiomed Therapeutics, Inc., which is intended to be covered by the safe harbor for “forward-looking statements” provided by the Private Securities Litigation Reform Act of 1995.

Contact: David R. Helton President, CEO and CSO Epiomed Therapeutics, Inc. 949-398-7359

SOURCE Epiomed Therapeutics, Inc.

Article source: http://www.heraldonline.com/2012/10/12/4332272/epiomed-and-nasa-sign-space-act.html

Tags: , , , <BR/>

NASA Partners With Forest Service To Highlight Wildfires, Science

/PRNewswire-USNewswire/ — NASA and the U.S. Forest Service signed a Space Act Agreement this week that unites the two agencies in raising awareness about the importance of fire prevention and fire safety.

(Logo: http://photos.prnewswire.com/prnh/20081007/38461LOGO)

This partnership will highlight areas of common interest in wildfires, forest and plant growth research and materials science. The joint effort will be enhanced by the personal interest of astronaut Joe Acaba, a flight engineer currently aboard the International Space Station. Acaba is an avid outdoorsman who has focused much of his career on the environment. He selected Smokey Bear, the forest service’s mascot, as the zero-gravity indicator and talisman for his Soyuz flight to the orbiting laboratory last month.

“I’ve always enjoyed the outdoors and our natural environment,” said Acaba. “When you view our planet from space, it only makes you appreciate it more. I hope that sharing my experiences aboard the space station will help others understand the importance of protecting our planet and protecting ourselves from Earth’s natural tendencies.”

Throughout the human spaceflight program, imagery of Earth has been a valuable asset to researchers on the ground. The dramatic views of smoke plumes and fire damage to communities from 240 miles above bring unparalleled perspectives of the effects of wildfire and the value of careful forestry resource management to people around the world. The images also help firefighters combat fires more effectively and help researchers learn about wildfire behavior and patterns.

Acaba and his station crewmates recorded high-resolution video and photographs June 28 of the wildfires now active in Colorado and Utah. These videos can be viewed on NASA’s website at:

http://go.nasa.gov/NXyttH

Crew observations and imagery of the Earth from space are just some areas that will be emphasized. Space station experiments that focus on improved understanding of plant growth and physiology, as well as combustion and materials science, also will have a prominent role in related outreach opportunities and events.

NASA and the U.S. Forest Service have worked together for decades in many areas of research and technology development, and the forest service provided invaluable assistance to NASA during recovery operations following the loss of space shuttle Columbia in the heavily wooded areas of East Texas.

For more information regarding NASA’s partnership with the U.S. Forest Service, visit:

http://go.nasa.gov/NHAlDd

For Acaba’s complete biography, visit:

http://www.jsc.nasa.gov/Bios/htmlbios/acaba-jm.html

For more information about International Space Station research, operations and crews, visit:

http://www.nasa.gov/station

SOURCE NASA

Article source: http://www.sacbee.com/2012/06/29/4599764/nasa-partners-with-forest-service.html

Tags: , , , , <BR/>

NASA Commercial Partner SpaceX Completes Crew Accommodations Milestone

/PRNewswire-USNewswire/ — Space Exploration Technologies (SpaceX) has finished an important evaluation of a prototype Dragon spacecraft designed to carry people into orbit. This key milestone is part of SpaceX’s partnership with NASA under a funded Space Act Agreement to advance the design of crew transportation vehicles.

(Logo: http://photos.prnewswire.com/prnh/20081007/38461LOGO)

The primary goal of the tests was to determine whether the layout will allow astronauts to maneuver effectively in the vehicle. Several veteran space shuttle astronauts and NASA engineers conducted the evaluation during a pair of two-day-long reviews.

“I am very pleased with the progress SpaceX and our other commercial partners are making during the CCDev2 effort,” said NASA Commercial Spaceflight Director Philip McAlister. “Together with NASA’s development of beyond low-Earth orbit systems, commercial crew and cargo transportation is an integral part of our overall human spaceflight program.”

As part of the Commercial Crew Development Round 2, or CCDev2, agreement, the company invited the astronauts and engineers to its headquarters in Hawthorne, Calif., to conduct the evaluation. The prototype was equipped with seats, lighting, environmental control and life support systems, conceptual displays and controls, cargo racks and other interior systems.

“This milestone demonstrated the layout of the crew cabin supports critical tasks,” said SpaceX Commercial Crew Development Manager Garrett Reisman. “It also demonstrated the Dragon interior has been designed to maximize the ability of the seven-member crew to do their job as effectively as possible.”

During the reviews, space shuttle veterans Rex Walheim, Tony Antonelli, Eric Boe and Tim Kopra participated in so-called “human factor assessments.” This included entering and exiting Dragon under normal and emergency scenarios. They also performed reach and visibility evaluations.

“As an anchor customer for commercial transportation services, we are happy to provide SpaceX with knowledge and lessons learned from our 50 years of human spaceflight,” said Commercial Crew Program Manager Ed Mango. “We appreciate the opportunity SpaceX gave us to provide feedback on these critical interior systems while the company maintains its flexibility to appeal to other customers.”

This is the seventh of 10 milestones SpaceX must meet under the CCDev2 agreement, which continues through July 31. This includes the development of a launch abort system for crew escape during launch or ascent.

All of NASA’s industry partners continue to meet their established milestones in developing safe, reliable and affordable commercial crew transportation capabilities.

For more information about NASA’s Commercial Crew Program, visit: http://www.nasa.gov/commercialcrew

SOURCE NASA

Article source: http://www.sacbee.com/2012/05/08/4475379/nasa-commercial-partner-spacex.html

Tags: , , , , , , <BR/>

NASA Commercial Partner SpaceX Completes Crew Accommodations Milestone


CAPE CANAVERAL, Fla., May 8, 2012 /PRNewswire via COMTEX/ –
Space Exploration Technologies (SpaceX) has finished an important evaluation of a prototype Dragon spacecraft designed to carry people into orbit. This key milestone is part of SpaceX’s partnership with NASA under a funded Space Act Agreement to advance the design of crew transportation vehicles.

The primary goal of the tests was to determine whether the layout will allow astronauts to maneuver effectively in the vehicle. Several veteran space shuttle astronauts and NASA engineers conducted the evaluation during a pair of two-day-long reviews.

“I am very pleased with the progress SpaceX and our other commercial partners are making during the CCDev2 effort,” said NASA Commercial Spaceflight Director Philip McAlister. “Together with NASA’s development of beyond low-Earth orbit systems, commercial crew and cargo transportation is an integral part of our overall human spaceflight program.”

As part of the Commercial Crew Development Round 2, or CCDev2, agreement, the company invited the astronauts and engineers to its headquarters in Hawthorne, Calif., to conduct the evaluation. The prototype was equipped with seats, lighting, environmental control and life support systems, conceptual displays and controls, cargo racks and other interior systems.

“This milestone demonstrated the layout of the crew cabin supports critical tasks,” said SpaceX Commercial Crew Development Manager Garrett Reisman. “It also demonstrated the Dragon interior has been designed to maximize the ability of the seven-member crew to do their job as effectively as possible.”

During the reviews, space shuttle veterans Rex Walheim, Tony Antonelli, Eric Boe and Tim Kopra participated in so-called “human factor assessments.” This included entering and exiting Dragon under normal and emergency scenarios. They also performed reach and visibility evaluations.

“As an anchor customer for commercial transportation services, we are happy to provide SpaceX with knowledge and lessons learned from our 50 years of human spaceflight,” said Commercial Crew Program Manager Ed Mango. “We appreciate the opportunity SpaceX gave us to provide feedback on these critical interior systems while the company maintains its flexibility to appeal to other customers.”

This is the seventh of 10 milestones SpaceX must meet under the CCDev2 agreement, which continues through July 31. This includes the development of a launch abort system for crew escape during launch or ascent.

All of NASA’s industry partners continue to meet their established milestones in developing safe, reliable and affordable commercial crew transportation capabilities.

For more information about NASA’s Commercial Crew Program, visit:

http://www.nasa.gov/commercialcrew

SOURCE NASA

Copyright (C) 2012 PR Newswire. All rights reserved

Article source: http://www.marketwatch.com/story/nasa-commercial-partner-spacex-completes-crew-accommodations-milestone-2012-05-08

Tags: , , , , , , <BR/>

NASA Offers Expertise to Help Private Companies Build Rockets, Capsules




Liberty rocket would revive part of NASA's scrapped Ares I rocket designe.

The new Liberty launch vehicle, which draws on parts of NASA’s cancelled Ares I rocket and Europe’s Ariane 5 rocket, will use existing infrastructure at Kennedy Space Center–including, possibly, the mobile launch platform shown in this illustration.
CREDIT: ATK

To help spur the development of a new fleet of commercial spacecraft to carry astronauts to and from the International Space Station, NASA has partnered with select private companies to foster the design and testing of the new vehicles. But the firms that received funding from NASA are not the only players in the game.

NASA has also made deals with several other commercial companies under so-called unfunded Space Act Agreements. As part of these arrangements, the agency provides expertise that could help the companies develop their vehicles or launch systems, but does not give out any money.

Utah-based Alliant Techsystems (ATK), the company that manufactured the space shuttles’ solid rocket boosters, signed an unfunded Space Act Agreement (SAA) with NASA in September to jointly work on the company’s Liberty rocket, which could launch astronauts into orbit by 2015 or 2016, company officials have said.

Also in September, ATK completed a full-scale test of its five-segment solid motor — the world’s largest solid rocket motor — in Utah’s high desert. The motor was originally designed to be the first stage of the Ares 1 rocket, which NASA planned to use to launch the Orion capsule on trips to the moon before the Constellation program was scrapped.



“With the SAA in place, we have been able to work closely with NASA’s Commercial Program and receive valuable feedback as we develop the Liberty System,” said Kent Rominger, ATK vice president and program manager for Liberty. “We continued to develop Liberty with the goal of providing the safest, most reliable, cost-effective and capable system for crew transport.”

A comparison of the new Liberty rocket compared to NASA's space shuttles and the Ariane 5 rocket, from which it borrows key technologies

ATK is building Liberty in partnership with the European aerospace firm Astrium. The rocket will use the original Ares 1 engine as a first stage, and Astrium’s Ariane 5 rocket as the second stage. The rocket will tower at 300 feet (91 meters) tall, company officials have said.

An initial design review for the launch system was completed in January, Rominger said, which brought together representatives from ATK, Astrium and other subcontractors. [The World's Tallest Rockets: How They Stack Up]

Libertywas submitted for consideration in the second round of NASA’s Commercial Crew Development program last year, but it was not selected to receive funding.

But the company’s Space Act Agreement with NASA, which runs through the spring, and stipulates that 12 to 24 full-time agency employees will help assess the design of Liberty, demonstrates NASA’s continued interest in the project, Ed Mango, NASA’s commercial crew program manager, said at the time.

ATK has submitted a proposal for the third and final funded phase of NASA’s commercial crew program, called Commercial Crew integrated Capability, or CCiCap. For proposals in this stage of the competition, companies are expected to present a complete launch system —rocket and vehicle — for consideration. ATK has not discussed specific details of their proposal, but company officials have said that work on the Liberty system is making steady progress. 

“The program is on schedule and we’ll discuss more of our plans before the awards are made,” Rominger told SPACE.com in an email. NASA is expected to announce their CCiCap selections this summer.

In late May, ATK is expected to conduct a structural test of the upper stage tank, followed by an analysis of the system’s software in June, he added.

With NASA’s space shuttle fleet now retired, the Liberty system is aiming to provide a flexible and cost- effective way to carry astronauts to the International Space Station.

“Because of the near-term schedule, low cost and high performance we can carry any spacecraft, have payload margin to also carry substantial cargo and return down-mass cargo,” Rominger said.

Using existing technology and infrastructure has also benefitted the program, and could help the process to man-rate the launch system go smoothly.

“Using qualified, proven and reliable systems is one of the major strengths of the program,” Rominger said. “Liberty provides tremendous value because it builds on European Ariane 5 launcher heritage, while allowing NASA to leverage the mature first stage. Both stages were also designed for human-rating since inception and would enable unmatched crew safety. In addition, we will launch it from the Kennedy Space Center using facilities that have already been built.”

But ATK and Astrium are not alone.

Excalibur Almaz, a private spaceflight company based on the Isle of Man, is working on repurposing space-flown hardware that was developed by the former Soviet Union. Company officials have said this approach will help cut costs and time during the development phase.

NASA announced it was entering into an unfunded Space Act Agreement with Excalibur Almaz in October.

You can follow SPACE.com staff writer Denise Chow on Twitter @denisechow. Follow SPACE.com for the latest in space science and exploration news on Twitter @Spacedotcom and on Facebook.

Article source: http://www.space.com/15464-nasa-private-spaceflight-unfunded-agreements.html

Tags: , , , <BR/>

Astrogenetix and NASA Sign Agreement to Continue Developing Medicines in Space …

AUSTIN, Texas, Feb 8, 2012 (GlobeNewswire via COMTEX) –
Astrogenetix Corporation, a subsidiary of Astrotech Corporation


/quotes/zigman/108159/quotes/nls/astc ASTC
+1.55%



, has entered into a Space Act Agreement (SAA) with NASA, (National Aeronautics and Space Administration). This SAA commits to providing the critical resources needed to continue utilizing the International Space Station (ISS) and to further the development of important on-orbit microgravity vaccines and therapeutic drug experiments.

Astrogenetix entered into a similar SAA in 2009 resulting in 12 successful missions on the Space Shuttle that led to the discovery of potential vaccine targets for both salmonella and MRSA. This experience clearly identified that the most important part of the discovery process is the repeated frequency of access to microgravity. The new SAA reflects this important priority and NASA has committed to provide a minimum of 28 missions between 2013 and 2016.

“Astrogenetix has been working with NASA for over three years to put the necessary agreements in place that would pave the way for the continued commercial utilization of the ISS. It is very clear that NASA shares in our commitment to utilize this most unique of all laboratories and continue with the very promising progress that we have already shown to be possible,” explained Astrogenetix Chairman, Thomas B. Pickens, III.

“As of December 2011, NASA has completed the construction of the International Space Station and with signing of this landmark SAA, the ISS is now realizing its vision of becoming a fully operational National Laboratory. The Agency is very committed to the commercial success of companies like Astrogenetix and we look forward to supporting this very important work,” said Mark Urhan, Director ISS, NASA.

About Astrogenetix, Incorporated

A subsidiary of Astrotech Corporation


/quotes/zigman/108159/quotes/nls/astc ASTC
+1.55%



, Astrogenetix is a biotechnology company formed to commercialize biotechnology products processed in the unique environment of microgravity. The Company offers a turn-key platform for pre-flight sample preparation, flight hardware, mission planning and operations, crew training and certification processes needed within the highly regulated and complex environment of manned space flight.

The Astrogenetix, Inc. logo is available at

http://www.globenewswire.com/newsroom/prs/?pkgid=7532

The statements in this document may contain forward-looking statements that are made pursuant to the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. Such forward-looking statements are subject to risks, trends, and uncertainties that could cause actual results to be materially different from the forward-looking statement. These factors include, but are not limited to, continued government support and funding for key space programs, product performance and market acceptance of products and services, as well as other risk factors and business considerations described in the company’s Securities Exchange Commission filings including the annual report on Form 10-K. Any forward-looking statements in this document should be evaluated in light of these important risk factors. The Company assumes no obligation to update these forward-looking statements.

This news release was distributed by GlobeNewswire,
www.globenewswire.com

SOURCE: Astrogenetix, Inc.



        CONTACT: John Porter
        Chief Executive Officer Astrogenetix, Inc.
        512.485.9530
        info@astrogenetix.com
        


(C) Copyright 2010 GlobeNewswire, Inc. All rights reserved.

/quotes/zigman/108159/quotes/nls/astc



add Add ASTC to portfolio

ASTC

loading...

/quotes/zigman/108159/quotes/nls/astc



add Add ASTC to portfolio

ASTC

loading...

Article source: http://www.marketwatch.com/story/astrogenetix-and-nasa-sign-agreement-to-continue-developing-medicines-in-space-to-save-lives-on-earth-2012-02-08

Tags: , , , , , , <BR/>

NASA Johnson Space Center to collaborate with Houston Technology Center


NASA Johnson Space Center and the Houston Technology Center will host a “Space Act Agreement” signing and announcement on Tuesday, Dec. 13.

NASA JSC and HTC have formed a strategic partnership to expand HTC’s mission of accelerating the growth of emerging technology companies in the Houston region to support NASA’s long-term goals of increasing private/public collaboration.

The event will feature remarks by Houston Mayor Annise Parker; Walter Ulrich, president  and CEO of HTC; and Michael Coats, the center director for the NASA Johnson Space Center, among others, as well as the signing of the agreement.

The event will be held from 1:45 p.m. to 3 p.m. at the NASA Johnson Space Center, located at 2101 NASA Parkway in Houston.

Article source: http://www.ultimateclearlake.com/stories/299028-events-nasa-johnson-space-center-to-collaborate-with-houston-technology-center

Tags: , , , , <BR/>

NASA makes a deal with booster builder for new rocket

NASA and ATK, the Utah-based company that built solid rocket boosters for the space shuttle, have announced a deal to work together on the development of a new commercial rocket.

Today’s Space Act agreement, which runs through next March, does not call for NASA to pay ATK. In fact, it’s conceivable that ATK could pay NASA for services rendered at Kennedy Space Center in Florida or elsewhere. But eventually ATK hopes that the Liberty rocket, built in cooperation with Europe’s EADS Astrium aerospace consortium, will be used to send astronauts to the International Space Station, with NASA paying the cost.

“This is going to be the home of Liberty,” Kent Rominger, vice president of strategy and business development for ATK Aerospace, told journalists at Kennedy Space Center during a news briefing.

That means ATK would have to buddy up with a spaceship company, such as the Boeing Co. (with its CST-100 crew vehicle) or Sierra Nevada Corp. (with its Dream Chaser space plane). ATK sees today’s agreement as a way to get through the door and make its pitch to those future spaceship providers.


Rominger said the Liberty rocket could be used by any of the space taxis currently being considered for NASA’s use.

ATK, or Alliant Techsystems, is already testing a modified version of its four-segment solid rocket booster for NASA’s future use. The latest on-the-ground engine test went off successfully just last week in Utah. Beefed-up versions of the booster could be used not only as part of the Liberty launch system but also as part of NASA’s more powerful Space Launch System, which is still in the planning stage.

The company had been working on a five-segment version of the booster for NASA’s Ares 1 rocket as an element to support NASA’s Constellation program to return astronauts to the moon, but Ares 1 went by the wayside when the back-to-the-moon effort was canceled. Today’s agreement could lead to a revival of at least a part of the Ares 1 program under a different name. 

Between now and next March, ATK and NASA would work together on the design of the Liberty rocket. The current design calls for the five-segment booster to serve as Liberty’s first stage, with an adapted version of Europe’s workhorse Ariane 5 rocket serving as the second stage. The rocket would be capable of lifting 44,000 pounds (20 metric tons) to low-Earth orbit, ATK says.

Although the company is working on hardware at its Utah facilities, no hardware would be delivered to NASA under the terms of the current agreement, Rominger said. “Right now, it’s paper,” he said.

Ed Mango, NASA’s commercial crew program manager, said the Liberty project provided an “outstanding opportunity” for international cooperation in the post-shuttle era.

John Schumacher, vice president of space programs for EADS North America, told journalists that the Liberty concept “brings together the best of U.S. and European launch capabilities.”

The Liberty rocket was proposed as an option for NASA development funding during the current phase of commercial crew vehicle development, but it lost out in that $269.3 million competition to four other firms that were building spacecraft: Boeing, Blue Origin, Sierra Nevada Corp. and SpaceX. ATK hopes to partner with spaceship builders to win NASA funding in the next phase of the commercial crew development program, or CCDev.

“We’re talking to everybody that we can,” Rominger said. Boeing, Blue Origin and Sierra Nevada have said they are initially aiming to use United Launch Alliance’s Atlas 5 vehicle, which is already supported by a Space Act agreement similar to ATK’s. SpaceX plans to use its own Falcon 9 rocket. Rominger acknowledged that SpaceX was not in the market for Liberty, but he voiced hope that ATK could strike a deal with other spaceship companies.

“We believe pricing-wise for the performance, nobody can match what Liberty can do,” he said.

Other tidbits:

  • Rominger said “our best guess” is that the first stage of the Liberty development effort would bring 300 jobs to Florida. Mango estimated that 50 individuals at NASA may be involved in the work with ATK under the Space Act agreement, but not full-time.
  • The testing schedule for Liberty depends on NASA’s future awards for the next phase of CCDev, but Rominger said the rocket could be ready by the time any spaceship was ready for flight. NASA is targeting the middle of the decade as the time frame for such flights. ATK’s news release says Liberty could be ready for its first test flight in 2014, leading to a crewed flight for the third launch in 2015.
  • If ATK loses out in the commercial crew vehicle competition, there would still be a business case for Liberty, “but it’s not as strong,” Rominger said. The rocket could also be used for launching satellites or transporting cargo to the International Space Station, he said.

More about the commercial space race:


Connect with the Cosmic Log community by “liking” the log’s Facebook page, following @b0yle on Twitter or adding me to your Google+ circle. You can also check out “The Case for Pluto,” my book about the controversial dwarf planet and the search for other worlds. 

Article source: http://cosmiclog.msnbc.msn.com/_news/2011/09/13/7745769-nasa-makes-a-deal-with-booster-builder-for-new-rocket

Tags: , , , , <BR/>